TY  - GEN
AU  - Liu,Joyce F
AU  - Herold,Christina
AU  - Gray,Kathryn P
AU  - Penson,Richard T
AU  - Horowitz,Neil
AU  - Konstantinopoulos,Panagiotis A
AU  - Castro,Cesar M
AU  - Hill,Sarah J
AU  - Curtis,Jennifer
AU  - Luo,Weixiu
AU  - Matulonis,Ursula A
AU  - Cannistra,Stephen A
AU  - Dizon,Don S
TI  - Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
SN  - 2374-2445
PY  - 2021///0616
KW  - Administration, Intravenous
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bevacizumab
KW  - Carcinoma, Ovarian Epithelial
KW  - drug therapy
KW  - Drug Administration Schedule
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Nivolumab
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - United States
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1001/jamaoncol.2019.3343
ER  -